Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?

Reproductive sciences (Thousand Oaks, Calif.) - 1 Feb 2020

Malentacchi Francesca, Turrini Irene, Sorbi Flavia, Projetto Elisabetta, Castiglione Francesca, Vergoni Federica, Amunni Gianni, Fambrini Massimiliano, Petraglia Felice, Noci Ivo, Pillozzi Serena

Abstract excerpt

The incidence of endometrial cancer (EC) is increasing in developed countries. The most frequent is the endometrioid subtype with usually good prognosis; nevertheless, some cases escape this paradigm and may have recurrence. A recent study from The Cancer Genome Atlas suggested to implement the EC analysis by molecular profile for improving diagnosis, prognosis, and therapeutic treatment. The present preliminary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Endometrioid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Mutation

Share to Pilot Projects

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Source

Identifiers

PMID: 32046431
DOI: 10.1007/s43032-019-00059-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a Gene Panel for Endometrioid Endometrial Cancer: a Possible Prognostic Value?PMID 32046431Read ↗

Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancerSemantic proximity Read ↗

Integrated genomic characterization of endometrial carcinomaSemantic proximity Read ↗

Tailoring Endometrial Cancer Treatment Based on Molecular Pathology: Current Status and Possible Impacts on Systemic and Local Treatment.Semantic proximity Read ↗

The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancerSemantic proximity Read ↗

Molecular testing for endometrial cancer: An SGO clinical practice statement.Semantic proximity Read ↗

Identification of TP53 mutated group using a molecular and immunohistochemical classification of endometrial carcinoma to improve prognostic evaluation for adjuvant treatments.Semantic proximity Read ↗

Endometrial Cancer: Transitioning from Histology to Genomics.Semantic proximity Read ↗

Molecular typing guiding treatment and prognosis of endometrial cancerSemantic proximity Read ↗

Molecular Genetics of Endometrial CarcinomaSemantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

Molecular Classification of Endometrial Cancer of Chinese PopulationSemantic proximity Read ↗

Genomic landscape of endometrial carcinomas of no specific molecular profile.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.